Medicamen Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020, to consider and approve Un-audited Financial Results (Standalone & Consolidated) for the half year ended on September 30, 2020.
The above information is a part of company’s filings submitted to BSE.